The global ADME Toxicology Testing Market is valued at USD 6.64 billion in 2025 and is projected to reach USD 14.40 billion by 2033, growing at a CAGR of 10.17%. The U.S. leads with a valuation of USD 2.18 billion in 2025, driven by pharmaceutical R&D spending and advanced testing models.

Preclinical ADME/Tox studies are rising with the discovery of new molecular entities and biologics. Outsourcing to CROs is accelerating time-to-market and reducing costs for drug developers globally.

Asia-Pacific is the fastest-growing region, thanks to China’s low-cost testing, expanding biotech infrastructure, and increasing biologics pipelines.

The ADME toxicology testing market is a crucial part of drug development, evaluating a compound’s ADME properties. The transition to in vitro and in silico testing platforms has enhanced speed and predictability in preclinical assessment.

High investments in R&D, preclinical infrastructure, and regulatory compliance have made the U.S. a market leader. The presence of large CROs and AI-based platforms have further strengthened its position.

The cell culture segment dominates the market with a revenue share of 44.82% in 2025. High throughput technology is expected to grow at a CAGR of 10.81% between 2026-2033.

Systemic toxicity is the largest revenue generator with approximately 54.88% market share in 2025. Renal toxicity segment is anticipated to grow the fastest with a CAGR of 10.96% by 2026-2033.

The pharmaceutical & biotechnology companies segment holds the largest share of the market at around 45.86% in 2025. Contract research organizations (CROs) are expected to have the highest CAGR of 10.49% during 2026–2033.

North America dominates the market with a 43.60% market share in 2025. Asia Pacific is the fastest-growing region, registering a CAGR of 11.10% over the forecast period. The ADME Toxicology Testing Market is projected to reach USD 6.64 billion by 2025 and USD 14.40 billion by 2033, with a CAGR of 10.17% from 2026 to 2033. Key segments include technology, application, method, and end-user. Regional analysis covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

S&S Insider offers comprehensive market research and consulting services globally. With a focus on providing clients with up-to-date market data, consumer insights, and opinions, our goal is to help businesses navigate changing circumstances and make informed decisions. Contact us for more information or customized research solutions at [email protected].

Read more at GlobeNewswire: ADME Toxicology Testing Market Size to Reach USD 14.40